Ozempic
from Maintenance Phase
by Aubrey Gordon & Michael Hobbes
Published: Tue Oct 10 2023
Show Notes
Ozempic is being hailed as “the end of the Obesity Epidemic.” This week, Mike and Aubrey dig through the sensational claims. But will they make it past the caveats?
Links:
- Howa Canadian scientist and a venomous lizard helped pave the way for Ozempic
- TheDiscovery and Development of Liraglutide and Semaglutide
- Ozempicand Wegovy maker courts prominent Black leaders to get Medicare's favor
- Insurersclamping down on doctors who prescribe Ozempic for weight loss
- Ozempicprescriptions can be easy to get online. Its popularity for weight loss is hurting those who need it most
- Glucagon-likepeptide-1 receptor agonists in patients with type 2 diabetes: real-world evidence from a Mediterranean area
- Semaglutidein Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- Real-worldweight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
- Safetyof Semaglutide
- Semaglutidefor the treatment of overweight and obesity: A review
- Once-WeeklySemaglutide in Adolescents with Obesity
- Semaglutide2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
- Associationof Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
- Real-WorldAdherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States
- Medicationsand conditions associated with weight loss in patients prescribed semaglutide based on real-world data
Thanks to Doctor Dreamchip for our lovely theme song!